-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KVjAQdfQQaoIpLpjbmYFxLfgLtIz9jd2WSclP7GC0kkA5WL7LU4PIg2ZjVzQtUGI UUvccam+VhmhYxTyxnN1aA== 0001238921-04-000002.txt : 20041025 0001238921-04-000002.hdr.sgml : 20041025 20041025165150 ACCESSION NUMBER: 0001238921-04-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041022 FILED AS OF DATE: 20041025 DATE AS OF CHANGE: 20041025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIBBERD CHRISTOPHER R CENTRAL INDEX KEY: 0001238921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 041094438 BUSINESS ADDRESS: STREET 1: C/O BIOSITE INC STREET 2: 11030 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584554808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2004-10-22 0 0000834306 BIOSITE INC BSTE 0001238921 HIBBERD CHRISTOPHER R BIOSITE INCORPORATED 11030 ROSELLE STREET SAN DIEGO CA 92121 0 1 0 0 SVP Bus Dlpmnt & Strat Plan Incentive Stock Option (right to buy) 49.15 2004-10-22 4 A 0 255 49.15 A 2014-10-22 Common Stock 255 255 D Non-Qualified Stock Option (right to buy) 49.15 2004-10-22 4 A 0 9745 49.15 A 2014-10-22 Common Stock 9745 9745 D Option vests in sixteen equal quarterly installments over four years (on each quarterly anniversary of the applicable vesting commencement date), provided that no shares may be exercised during the first six (6) month period following the commencement of vesting. By: Robyn Shutak For: Chris R. Hibberd 2004-10-25 -----END PRIVACY-ENHANCED MESSAGE-----